SCHEMBL1695814

SCHEMBL1695814

N#CCCNC(=O)C(=Cc1ccc(Cl)cc1)c1ccc(OCc2cn3ccccc3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ TDP1 Q9NUW8 5/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ PDE10A Q9Y233 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ HPGD P15428 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TSHR P16473 1/20 0.40
▸ HCRTR1 O43613 1/20 0.39
▸ GUSB P08236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695910 0.87 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL1695828 0.87 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL1695688 0.84 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL1695687 0.84 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL1695633 0.83 PARP10 (0.46) KDM4ESMN1; SMN2ALDH1A1TDP1NPC1
SCHEMBL1695635 0.83 PARP10 (0.46) KDM4ESMN1; SMN2ALDH1A1TDP1NPC1
SCHEMBL1695710 0.82 GPBAR1 (0.50) L3MBTL1PDE10AMAPT
SCHEMBL1695758 0.82 GPBAR1 (0.50) L3MBTL1PDE10AMAPT
SCHEMBL1695711 0.82 GPBAR1 (0.50) L3MBTL1PDE10AMAPT
SCHEMBL1695756 0.82 GPBAR1 (0.50) L3MBTL1PDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
Send feedback